Lista de obras - Tina S Skinner-Adams - Dominio Público Uruguay

A Subset Screen of the Compounds Australia Scaffold Library Identifies 7-Acylaminodibenzoxazepinones as Potent and Selective Hits for Anti-Giardia Drug Discovery

artículo científico publicado en 2022

A novel Plasmodium falciparum ring stage protein, REX, is located in Maurer's clefts

artículo científico publicado en 2004

Activity of bromodomain protein inhibitors/binders against asexual-stage Plasmodium falciparum parasites

artículo científico publicado en 2018

Adaptation of the [3H]Hypoxanthine Uptake Assay for In Vitro-Cultured Plasmodium knowlesi Malaria Parasites.

artículo científico publicado en 2016

Aminopeptidases of malaria parasites: new targets for chemotherapy.

artículo científico publicado en 2010

An ELISA method to assess HDAC inhibitor-induced alterations to P. falciparum histone lysine acetylation

scientific article published on 02 November 2020

An image-based Pathogen Box screen identifies new compounds with anti-Giardia activity and highlights the importance of assay choice in phenotypic drug discovery

artículo científico publicado en 2020

Anti-Giardia Drug Discovery: Current Status and Gut Feelings

scientific article published on 16 September 2020

Antimalarial Isocyano and Isothiocyanato Sesquiterpenes with Tri- and Bicyclic Skeletons from the Nudibranch Phyllidia ocellata

artículo científico publicado en 2015

Antimalarial activity of compounds comprising a primary benzene sulfonamide fragment.

artículo científico publicado en 2013

Antimalarial activity of sera from subjects taking HIV protease inhibitors.

artículo científico publicado en 2007

Antimalarial activity of the anticancer histone deacetylase inhibitor SB939.

artículo científico publicado en 2012

Antimalarial asexual stage-specific and gametocytocidal activities of HIV protease inhibitors

artículo científico publicado en 2009

Antiplasmodial activity of the natural product compounds alstonine and himbeline

artículo científico publicado en 2021

Antiplasmodial and antioxidant isofuranonaphthoquinones from the roots of Bulbine capitata.

artículo científico publicado en 2001

Antiretrovirals as antimalarial agents.

artículo científico publicado en 2004

CLAG 9 is located in the rhoptries of Plasmodium falciparum.

artículo científico publicado en 2004

Catalyst-Controlled Stereoselective Synthesis Secures the Structure of the Antimalarial Isocyanoterpene Pustulosaisonitrile-1.

artículo científico publicado en 2017

Characterization of the Plasmodium falciparum M17 leucyl aminopeptidase. A protease involved in amino acid regulation with potential for antimalarial drug development

artículo científico publicado en 2007

Characterization of the effect of retinol on Plasmodium falciparum in vitro.

artículo científico publicado en 2004

Comparison of Plasmodium falciparum transfection methods

artículo científico publicado en 2003

Correction to Catalyst-Controlled Stereoselective Synthesis Secures the Structure of the Antimalarial Isocyanoterpene Pustulosaisonitrile-1

scientific article published on 31 July 2018

Cyclization-blocked proguanil as a strategy to improve the antimalarial activity of atovaquone

artículo científico publicado en 2019

Defining the targets of antiparasitic compounds.

artículo científico publicado en 2016

Drug repurposing and human parasitic protozoan diseases

artículo científico publicado en 2014

Drug resistance in Giardia: Mechanisms and alternative treatments for Giardiasis

artículo científico publicado en 2020

Effect of antimalarial drugs on Plasmodium falciparum gametocytes.

artículo científico publicado en 2009

Effect of clinically approved HDAC inhibitors on Plasmodium, Leishmania and Schistosoma parasite growth.

artículo científico publicado en 2016

Erratum to "Profiling the anti-protozoal activity of anti-cancer HDAC inhibitors against Plasmodium and Trypanosoma parasites" [Int. J. Parasitol. Drugs Drug Res. 5 (2015) 117-126].

artículo científico publicado en 2016

Fingerprinting the substrate specificity of M1 and M17 aminopeptidases of human malaria, Plasmodium falciparum

artículo científico publicado en 2012

Fragment-Based Screening of a Natural Product Library against 62 Potential Malaria Drug Targets Employing Native Mass Spectrometry

artículo científico publicado en 2018

GATEWAY vectors for Plasmodium falciparum transfection

artículo científico publicado en 2003

HIV and malaria co-infection: interactions and consequences of chemotherapy.

artículo científico publicado en 2008

HIV-1 protease inhibitors and clinical malaria: a secondary analysis of the AIDS Clinical Trials Group A5208 study

artículo científico publicado en 2011

HIV-malaria interactions: don't forget the drugs.

artículo científico publicado en 2007

Heterogeneous activity in vitro of vitamin A (retinol) in combination with novel and established antimalarial drugs.

artículo científico publicado en 1999

Histone deacetylase inhibitor AR-42 and achiral analogues kill malaria parasites in vitro and in mice

artículo científico publicado en 2021

Identification of Potent and Selective Inhibitors of the Plasmodium falciparum M18 Aspartyl Aminopeptidase (PfM18AAP) of Human Malaria via High-Throughput Screening.

artículo científico publicado en 2014

Identification of novel quinazoline derivatives as potent antiplasmodial agents

artículo científico publicado en 2018

Identification of phosphinate dipeptide analog inhibitors directed against the Plasmodium falciparum M17 leucine aminopeptidase as lead antimalarial compounds.

artículo científico publicado en 2007

Implication of a Plasmodium falciparum gene in the switch between asexual reproduction and gametocytogenesis

artículo científico publicado en 2005

In vitro antimalarial activity of trovafloxacin, a fourth-generation fluoroquinolone

artículo científico publicado en 2000

In vitro growth inhibition of Plasmodium falciparum by retinol at concentrations present in normal human serum.

artículo científico publicado en 1998

Inhibition of growth in vitro of Plasmodium falciparum by vitamin E (alpha-tocopherol).

artículo científico publicado en 1998

Inhibition of hypoxanthine-guanine phosphoribosyltransferase by acyclic nucleoside phosphonates: a new class of antimalarial therapeutics

artículo científico publicado en 2009

Inhibitors of the Plasmodium falciparum M17 Leucine Aminopeptidase

artículo científico publicado en 2010

Inhibitors of the Plasmodium falciparum M18 Aspartyl Aminopeptidase

artículo científico publicado en 2014

Lead compounds for antimalarial chemotherapy: purine base analogs discriminate between human and P. falciparum 6-oxopurine phosphoribosyltransferases

scientific article published on 01 December 2006

Lysine acetylation in sexual stage malaria parasites is a target for antimalarial small molecules.

artículo científico publicado en 2014

Malaria transfection and transfection vectors.

artículo científico publicado en 2003

Mollemycin A: an antimalarial and antibacterial glyco-hexadepsipeptide-polyketide from an Australian marine-derived Streptomyces sp. (CMB-M0244).

artículo científico publicado en 2014

Overexpression of leucyl aminopeptidase in Plasmodium falciparum parasites. Target for the antimalarial activity of bestatin

artículo científico publicado en 2005

Plagiarism

artículo científico publicado en 2009

Plasmodium falciparum gametocytes: with a view to a kill.

artículo científico

Plasmodium falciparum neutral aminopeptidases: new targets for anti-malarials

scientific article published on 30 September 2009

Plasmodium falciparum: isolate-specific radiosensitivity.

artículo científico publicado en 2001

Plasmodium falciparum: new molecular targets with potential for antimalarial drug development

artículo científico publicado en 2009

Plasmodium gametocyte inhibition identified from a natural-product-based fragment library

artículo científico publicado en 2013

Potencies of human immunodeficiency virus protease inhibitors in vitro against Plasmodium falciparum and in vivo against murine malaria

artículo científico publicado en 2006

Potent antimalarial activity of histone deacetylase inhibitor analogues.

artículo científico publicado en 2008

Profiling the anti-protozoal activity of anti-cancer HDAC inhibitors against Plasmodium and Trypanosoma parasites

artículo científico publicado en 2015

Proteomic analysis of Plasmodium falciparum histone deacetylase 1 complex proteins

Psammaplysin derivatives from the Balinese marine sponge Aplysinella strongylata

artículo científico publicado en 2012

Saquinavir inhibits the malaria parasite's chloroquine resistance transporter.

artículo científico publicado en 2012

Stronger activity of human immunodeficiency virus type 1 protease inhibitors against clinical isolates of Plasmodium vivax than against those of P. falciparum.

artículo científico publicado en 2008

Structural basis for the inhibition of the essential Plasmodium falciparum M1 neutral aminopeptidase

artículo científico publicado en 2009

Structure of the Plasmodium falciparum M17 aminopeptidase and significance for the design of drugs targeting the neutral exopeptidases

artículo científico publicado en 2010

Structure-Activity and Structure-Toxicity Relationships of Peptoid-Based Histone Deacetylase Inhibitors with Dual-Stage Antiplasmodial Activity

artículo científico publicado en 2019

Synergistic in vitro antimalarial activity of omeprazole and quinine.

artículo científico publicado en 1999

Synergistic interactions of the antiretroviral protease inhibitors saquinavir and ritonavir with chloroquine and mefloquine against Plasmodium falciparum in vitro.

artículo científico publicado en 2006

Synthesis and Antiplasmodial Evaluation of Analogues Based on the Tricyclic Core of Thiaplakortones A-D.

artículo científico publicado en 2015

Synthesis, antimalarial properties, and SAR studies of alkoxyurea-based HDAC inhibitors.

artículo científico publicado en 2014

Synthesis, biological characterisation and structure activity relationships of aromatic bisamidines active against Plasmodium falciparum

artículo científico publicado en 2016

The Aminopeptidase Inhibitor CHR-2863 Is an Orally Bioavailable Inhibitor of Murine Malaria ⬇️

artículo científico publicado el 26 de marzo de 2012

The Frequency of Malaria Is Similar among Women Receiving either Lopinavir/Ritonavir or Nevirapine-based Antiretroviral Treatment ⬇️

artículo científico publicado el 3 de abril de 2012

The Key Glycolytic Enzyme Phosphofructokinase Is Involved in Resistance to Antiplasmodial Glycosides.

artículo científico publicado en 2020

The M17 leucine aminopeptidase of the malaria parasite Plasmodium falciparum: importance of active site metal ions in the binding of substrates and inhibitors.

artículo científico publicado en 2009

The M18 aspartyl aminopeptidase of the human malaria parasite Plasmodium falciparum.

artículo científico publicado en 2007

The activity of protease inhibitors against Giardia duodenalis and metronidazole-resistant Trichomonas vaginalis.

artículo científico publicado en 2006

The efficacy of benzimidazole drugs against Plasmodium falciparum in vitro ⬇️

artículo científico publicado el 1 de septiembre de 1997

Thieno[3,2-b]pyrrole 5-carboxamides as potent and selective inhibitors of Giardia duodenalis

artículo científico publicado en 2023

Total synthesis of thiaplakortone a: derivatives as metabolically stable leads for the treatment of malaria

artículo científico publicado en 2013

Lista de obras de Tina S Skinner-Adams

A Subset Screen of the Compounds Australia Scaffold Library Identifies 7-Acylaminodibenzoxazepinones as Potent and Selective Hits for Anti-Giardia Drug Discovery

A novel Plasmodium falciparum ring stage protein, REX, is located in Maurer's clefts

Activity of bromodomain protein inhibitors/binders against asexual-stage Plasmodium falciparum parasites

Adaptation of the [3H]Hypoxanthine Uptake Assay for In Vitro-Cultured Plasmodium knowlesi Malaria Parasites.

Aminopeptidases of malaria parasites: new targets for chemotherapy.

An ELISA method to assess HDAC inhibitor-induced alterations to P. falciparum histone lysine acetylation

An image-based Pathogen Box screen identifies new compounds with anti-Giardia activity and highlights the importance of assay choice in phenotypic drug discovery

Anti-Giardia Drug Discovery: Current Status and Gut Feelings

Antimalarial Isocyano and Isothiocyanato Sesquiterpenes with Tri- and Bicyclic Skeletons from the Nudibranch Phyllidia ocellata

Antimalarial activity of compounds comprising a primary benzene sulfonamide fragment.

Antimalarial activity of sera from subjects taking HIV protease inhibitors.

Antimalarial activity of the anticancer histone deacetylase inhibitor SB939.

Antimalarial asexual stage-specific and gametocytocidal activities of HIV protease inhibitors

Antiplasmodial activity of the natural product compounds alstonine and himbeline

Antiplasmodial and antioxidant isofuranonaphthoquinones from the roots of Bulbine capitata.

Antiretrovirals as antimalarial agents.

CLAG 9 is located in the rhoptries of Plasmodium falciparum.

Catalyst-Controlled Stereoselective Synthesis Secures the Structure of the Antimalarial Isocyanoterpene Pustulosaisonitrile-1.

Characterization of the Plasmodium falciparum M17 leucyl aminopeptidase. A protease involved in amino acid regulation with potential for antimalarial drug development

Characterization of the effect of retinol on Plasmodium falciparum in vitro.

Comparison of Plasmodium falciparum transfection methods

Correction to Catalyst-Controlled Stereoselective Synthesis Secures the Structure of the Antimalarial Isocyanoterpene Pustulosaisonitrile-1

Cyclization-blocked proguanil as a strategy to improve the antimalarial activity of atovaquone

Defining the targets of antiparasitic compounds.

Drug repurposing and human parasitic protozoan diseases

Drug resistance in Giardia: Mechanisms and alternative treatments for Giardiasis

Effect of antimalarial drugs on Plasmodium falciparum gametocytes.

Effect of clinically approved HDAC inhibitors on Plasmodium, Leishmania and Schistosoma parasite growth.

Erratum to "Profiling the anti-protozoal activity of anti-cancer HDAC inhibitors against Plasmodium and Trypanosoma parasites" [Int. J. Parasitol. Drugs Drug Res. 5 (2015) 117-126].

Fingerprinting the substrate specificity of M1 and M17 aminopeptidases of human malaria, Plasmodium falciparum

Fragment-Based Screening of a Natural Product Library against 62 Potential Malaria Drug Targets Employing Native Mass Spectrometry

GATEWAY vectors for Plasmodium falciparum transfection

HIV and malaria co-infection: interactions and consequences of chemotherapy.

HIV-1 protease inhibitors and clinical malaria: a secondary analysis of the AIDS Clinical Trials Group A5208 study

HIV-malaria interactions: don't forget the drugs.

Heterogeneous activity in vitro of vitamin A (retinol) in combination with novel and established antimalarial drugs.

Histone deacetylase inhibitor AR-42 and achiral analogues kill malaria parasites in vitro and in mice

Identification of Potent and Selective Inhibitors of the Plasmodium falciparum M18 Aspartyl Aminopeptidase (PfM18AAP) of Human Malaria via High-Throughput Screening.

Identification of novel quinazoline derivatives as potent antiplasmodial agents

Identification of phosphinate dipeptide analog inhibitors directed against the Plasmodium falciparum M17 leucine aminopeptidase as lead antimalarial compounds.

Implication of a Plasmodium falciparum gene in the switch between asexual reproduction and gametocytogenesis

In vitro antimalarial activity of trovafloxacin, a fourth-generation fluoroquinolone

In vitro growth inhibition of Plasmodium falciparum by retinol at concentrations present in normal human serum.

Inhibition of growth in vitro of Plasmodium falciparum by vitamin E (alpha-tocopherol).

Inhibition of hypoxanthine-guanine phosphoribosyltransferase by acyclic nucleoside phosphonates: a new class of antimalarial therapeutics

Inhibitors of the Plasmodium falciparum M17 Leucine Aminopeptidase

Inhibitors of the Plasmodium falciparum M18 Aspartyl Aminopeptidase

Lead compounds for antimalarial chemotherapy: purine base analogs discriminate between human and P. falciparum 6-oxopurine phosphoribosyltransferases

Lysine acetylation in sexual stage malaria parasites is a target for antimalarial small molecules.

Malaria transfection and transfection vectors.

Mollemycin A: an antimalarial and antibacterial glyco-hexadepsipeptide-polyketide from an Australian marine-derived Streptomyces sp. (CMB-M0244).

Overexpression of leucyl aminopeptidase in Plasmodium falciparum parasites. Target for the antimalarial activity of bestatin

Plagiarism

Plasmodium falciparum gametocytes: with a view to a kill.

Plasmodium falciparum neutral aminopeptidases: new targets for anti-malarials

Plasmodium falciparum: isolate-specific radiosensitivity.

Plasmodium falciparum: new molecular targets with potential for antimalarial drug development

Plasmodium gametocyte inhibition identified from a natural-product-based fragment library

Potencies of human immunodeficiency virus protease inhibitors in vitro against Plasmodium falciparum and in vivo against murine malaria

Potent antimalarial activity of histone deacetylase inhibitor analogues.

Profiling the anti-protozoal activity of anti-cancer HDAC inhibitors against Plasmodium and Trypanosoma parasites

Proteomic analysis of Plasmodium falciparum histone deacetylase 1 complex proteins

Psammaplysin derivatives from the Balinese marine sponge Aplysinella strongylata

Saquinavir inhibits the malaria parasite's chloroquine resistance transporter.

Stronger activity of human immunodeficiency virus type 1 protease inhibitors against clinical isolates of Plasmodium vivax than against those of P. falciparum.

Structural basis for the inhibition of the essential Plasmodium falciparum M1 neutral aminopeptidase

Structure of the Plasmodium falciparum M17 aminopeptidase and significance for the design of drugs targeting the neutral exopeptidases

Structure-Activity and Structure-Toxicity Relationships of Peptoid-Based Histone Deacetylase Inhibitors with Dual-Stage Antiplasmodial Activity

Synergistic in vitro antimalarial activity of omeprazole and quinine.

Synergistic interactions of the antiretroviral protease inhibitors saquinavir and ritonavir with chloroquine and mefloquine against Plasmodium falciparum in vitro.

Synthesis and Antiplasmodial Evaluation of Analogues Based on the Tricyclic Core of Thiaplakortones A-D.

Synthesis, antimalarial properties, and SAR studies of alkoxyurea-based HDAC inhibitors.

Synthesis, biological characterisation and structure activity relationships of aromatic bisamidines active against Plasmodium falciparum

The Aminopeptidase Inhibitor CHR-2863 Is an Orally Bioavailable Inhibitor of Murine Malaria ⬇️

The Frequency of Malaria Is Similar among Women Receiving either Lopinavir/Ritonavir or Nevirapine-based Antiretroviral Treatment ⬇️

The Key Glycolytic Enzyme Phosphofructokinase Is Involved in Resistance to Antiplasmodial Glycosides.

The M17 leucine aminopeptidase of the malaria parasite Plasmodium falciparum: importance of active site metal ions in the binding of substrates and inhibitors.

The M18 aspartyl aminopeptidase of the human malaria parasite Plasmodium falciparum.

The activity of protease inhibitors against Giardia duodenalis and metronidazole-resistant Trichomonas vaginalis.